These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35577625)

  • 21. Retrospective Study of the Characteristics of Anticoagulant-Type Rodenticide Poisoning in Hong Kong.
    Ng WY; Ching CK; Chong YK; Ng SW; Cheung WL; Mak TWL
    J Med Toxicol; 2018 Sep; 14(3):218-228. PubMed ID: 29687220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. K2--not the spice of life; synthetic cannabinoids and ST elevation myocardial infarction: a case report.
    McKeever RG; Vearrier D; Jacobs D; LaSala G; Okaneku J; Greenberg MI
    J Med Toxicol; 2015 Mar; 11(1):129-31. PubMed ID: 25154434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strokes are possible complications of cannabinoids use.
    Wolff V; Jouanjus E
    Epilepsy Behav; 2017 May; 70(Pt B):355-363. PubMed ID: 28237318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ingestion of superwarfarin leading to coagulopathy: a case report and review of the literature.
    Nelson AT; Hartzell JD; More K; Durning SJ
    MedGenMed; 2006 Nov; 8(4):41. PubMed ID: 17415322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthetic Cannabinoid-Associated Coagulopathy: Case Report.
    Micula-Gondek W; Ruales V; Zorn C; Angelino A
    Psychosomatics; 2019; 60(2):211-215. PubMed ID: 30104022
    [No Abstract]   [Full Text] [Related]  

  • 26. A review of clinical manifestations in adolescent and young adults after use of synthetic cannabinoids.
    Brewer TL; Collins M
    J Spec Pediatr Nurs; 2014 Apr; 19(2):119-26. PubMed ID: 24320158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthetic cannabinoid: an unexpected cause of coagulopathy.
    Tran MH; Perez-Alvarez I; Swaroop B
    Transfusion; 2018 Nov; 58(11):2743-2744. PubMed ID: 30403413
    [No Abstract]   [Full Text] [Related]  

  • 28. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
    Rice J; Cameron M
    Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction between warfarin and cannabis.
    Damkier P; Lassen D; Christensen MMH; Madsen KG; Hellfritzsch M; Pottegård A
    Basic Clin Pharmacol Toxicol; 2019 Jan; 124(1):28-31. PubMed ID: 30326170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factor IX complex for the correction of traumatic coagulopathy.
    Joseph B; Amini A; Friese RS; Houdek M; Hays D; Kulvatunyou N; Wynne J; O'Keeffe T; Latifi R; Rhee P
    J Trauma Acute Care Surg; 2012 Apr; 72(4):828-34. PubMed ID: 22491593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthetic Cannabinoids: Psychopharmacology, Clinical Aspects, Psychotic Onset.
    Martinotti G; Santacroce R; Papanti D; Elgharably Y; Prilutskaya M; Corazza O
    CNS Neurol Disord Drug Targets; 2017; 16(5):567-575. PubMed ID: 28412921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxicology of Marijuana, Synthetic Cannabinoids, and Cannabidiol in Dogs and Cats.
    Brutlag A; Hommerding H
    Vet Clin North Am Small Anim Pract; 2018 Nov; 48(6):1087-1102. PubMed ID: 30342565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic Use of Synthetic Cannabinoids: Still an OpenIssue?
    De Luca MA; Fattore L
    Clin Ther; 2018 Sep; 40(9):1457-1466. PubMed ID: 30180974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and financial implications of emergency department visits for synthetic marijuana.
    Rowley E; Benson D; Tiffee A; Hockensmith A; Zeng H; Jones GN; Musso MW
    Am J Emerg Med; 2017 Oct; 35(10):1506-1509. PubMed ID: 28457767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolonged coagulopathy related to coumarin rodenticide in a young patient: superwarfarin poisoning.
    Altay S; Cakmak HA; Boz GC; Koca S; Velibey Y
    Cardiovasc J Afr; 2012 Oct; 23(9):e9-e11. PubMed ID: 23108575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An outbreak of severe coagulopathy from synthetic cannabinoids tainted with Long-Acting anticoagulant rodenticides.
    Devgun JM; Rasin A; Kim T; Mycyk MB; Bryant SM; Wahl MS; DesLauriers C; Navon L; Moritz ED; Thompson TM; Swoboda HD; Lu J; Aks SE
    Clin Toxicol (Phila); 2020 Aug; 58(8):821-828. PubMed ID: 31797705
    [No Abstract]   [Full Text] [Related]  

  • 37. The Pharmacologic and Clinical Effects of Illicit Synthetic Cannabinoids.
    White CM
    J Clin Pharmacol; 2017 Mar; 57(3):297-304. PubMed ID: 27610597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings.
    Hermanns-Clausen M; Kneisel S; Szabo B; Auwärter V
    Addiction; 2013 Mar; 108(3):534-44. PubMed ID: 22971158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Critical Illness Secondary to Synthetic Cannabinoid Ingestion.
    Kourouni I; Mourad B; Khouli H; Shapiro JM; Mathew JP
    JAMA Netw Open; 2020 Jul; 3(7):e208516. PubMed ID: 32687586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic potential of cannabinoids in combination cancer therapy.
    Malhotra P; Casari I; Falasca M
    Adv Biol Regul; 2021 Jan; 79():100774. PubMed ID: 33422460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.